- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00717613
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting
January 18, 2018 updated by: David Latini, Baylor College of Medicine
This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation).
We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.
Study Overview
Status
Completed
Conditions
Detailed Description
Interviews are conducted over the telephone and require approximately 90 minutes to complete.
Men interviewed are compensated for their participation in the study.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Convenience sample of men on active surveillance drawn from large academic medical centers, community hospitals, support groups, and the internet.
Description
Inclusion Criteria:
- 1) male,
- 2) 18 years or older, with biopsy-proven prostate cancer,
- 3) diagnosed with localized disease within the last 24 months,
- 4) have a telephone at the time of enrollment,
- 5) have an address where they can receive study materials by mail (a street address or post office box),
- 6) able to speak and understand English;
- 7) have selected surveillance, rather than active treatment for his prostate cancer.
Exclusion Criteria:
- 1) female
- 2) no diagnosis of localized prostate cancer
- 3) completed or undergoing active treatment (e.g., surgery, radiotherapy, etc.)
- 4) no phone or US mail address
- 5) unwilling or unable to provide informed consent
- 6) unable to speak and understand English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Observational cohort study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Health-related quality of life, particularly cancer-specific anxiety and general anxiety
Time Frame: One time retrospective interview
|
One time retrospective interview
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David M Latini, PhD, Baylor College of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2007
Primary Completion (Actual)
October 1, 2009
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
July 16, 2008
First Submitted That Met QC Criteria
July 16, 2008
First Posted (Estimate)
July 17, 2008
Study Record Updates
Last Update Posted (Actual)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 18, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DLD2007-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Localized Prostate Cancer
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsNot yet recruiting
-
BayerRecruiting
-
Radboud University Medical CenterNot yet recruitingHigh Risk Localized Prostate Cancer | Synchronous Metastatic Hormone-Sensitive Prostate Cancer
-
Arizona Oncology ServicesUnknownLocalized Breast Cancer | Localized Prostate Cancer | Patients Receiving External Beam RadiotherapyUnited States
-
Steba Biotech S.A.WithdrawnLocalized Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate Cancer | Localized Prostate CancerUnited States
-
Kenneth Pienta, MDProstate Cancer Foundation NorwayWithdrawnProstate Cancer | Localized Prostate CancerUnited States
-
Shanghai Proton and Heavy Ion CenterRecruitingLocalized Prostate CancerChina
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
Momotaro-Gene Inc.The Pacific Link Consulting CoCompletedLocalized Prostate CancerUnited States